Vitamin D3 for Life

Live Enlightened

Article

VDR Variants, Receptor Activity and Gene Regulation: Study Summary

Previous related pageVDR Variants, Receptor Activity and Gene Regulation: Full Evidence ReviewNext related pageVDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Full Evidence Review
Study at a glance

How can gene differences change the vitamin D receptor?

This page summarises how common differences in the vitamin D receptor gene can affect the receptor in different ways. Some change the receptor protein itself. Others can change how much receptor a cell makes or how its production is controlled.

What did studies find about vitamin D receptor gene differences?

A gene difference called FokI can produce a shorter receptor protein. This shorter form showed greater activity in some laboratory tests, but other tests found no significant difference. Three other commonly studied differences, BsmI, ApaI and TaqI, do not change the sequence of building blocks in the receptor protein. They occur in groups of linked gene differences that may affect receptor production. Studies disagree about whether these groups change how long RNA messages carrying instructions for making the receptor remain usable. Other gene differences affect regions that control gene activity or interactions with small RNA molecules.

Does a vitamin D receptor gene difference always have the same effect?

A gene difference may not have the same effect in every tissue or experimental setting. FokI cannot be ranked as always more or less active. BsmI, ApaI and TaqI should not be described as changes to the receptor protein itself. Finding a link between a gene difference and a disease does not, on its own, show how the receptor works.

Read the full article below ↓

What is the main point?

Common vitamin D receptors can be influenced by functionally heterogeneous genetic variants. Some can change receptor protein structure, some can alter VDR transcription, and others sit in linked 3′-region regulatory haplotypes.

What does FokI do?

FokI can change the translation start site and produce VDR proteins of different N-terminal length. The shorter isoform has shown stronger interaction with transcription factor IIB and greater transactivation in some systems, but other direct functional assays found no significant difference. FokI therefore has a plausible functional effect, not a universal activity ranking.

What about BsmI, ApaI and TaqI?

These common variants do not directly change the VDR amino-acid sequence. Their interpretation sits within the broader framework of vitamin D genetics. They sit in a linked 3′-region where haplotypes may influence VDR expression or RNA handling. Functional studies disagree on whether common haplotypes consistently alter mRNA stability, so the effect must remain qualified.

Why do promoter and microRNA variants matter?

Promoter variants such as those in Cdx2/GATA regions can alter VDR transcription, while rs739837 lies in a 3′-UTR microRNA-regulatory context. These mechanisms affect receptor abundance or regulation rather than receptor structure.

What should not be concluded?

  • No common VDR polymorphism should be assumed to have the same functional effect in every tissue.
  • BsmI, ApaI and TaqI should not be described as protein-altering mutations.
  • Association with disease does not by itself prove receptor mechanism.
  • FokI should not be labelled universally ‘more active’ or ‘less active’.

Primary evidence and publication details

Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401-420.

Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res. 1998;13:1691-1699.

Fang Y, van Meurs JBJ, d’Alesio A, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study. Am J Hum Genet. 2005;77:807-823.

Durrin LK, Haile RW, Ingles SA, Coetzee GA. Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta. 1999;1453:311-320.

Ji X, Mao J, Zhou S. Rs739837 Polymorphism in MiR-885-3p Binding Site Within 3′-Untranslated Region of Vitamin D Receptor is Associated with a Decreased Risk of Pressure Ulcers. Cell Physiol Biochem. 2017;44:2129-2137.

Related reading

Physiology

Vitamin D Receptors

A physiology-first explanation of vitamin D receptors, covering cellular detection, transcriptional regulation, signalling integration, and tissue-specific responsiveness.

Read more →

Original sources